Ask AI

A Master Class in CP-CML: New Agents, Treatment Goals, and Clinical Challenges

Gain expert insights into evidence-based individualized approaches for frontline treatment of chronic-phase CML and how to incorporate molecular and mutational monitoring to optimize individualized patient outcomes through a certified on-demand webcast, expert-authored ClinicalThought commentary, and accompanying downloadable slides.

Share

Program Content

Activities

CP CML Frontline TKIs
Evolving Standard of Care for Frontline TKI Therapy in CP-CML Clinical Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2025

CP-CML: TKI Intolerance
Grappling With First-line Treatment Intolerance in CP-CML: What Are the Next Best Options for Patients?
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2025

Monitoring Response in CP CML
Optimal Risk Assessment, Response Monitoring, and Testing for TKI Resistance in Patients With CP-CML
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2025

Activities

Master Class in CP CML
A Master Class in CP-CML: New Agents, Treatment Goals, and Clinical Challenges
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 29, 2025

Expires: June 28, 2026

Activities

Cases in CP CML
Expert Insights on Real-world Cases of TKI Therapy for Patients With CP-CML
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 26, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation